Good Scientists, Bad Science? How To Respond To 'Renegade' Researchers

Case One: The Molecular biologist who refuses to believe that AIDS is caused by a virus BERKELEY, CALIF.—On a Saturday early in April, as Washington’s famous cherry trees began to blossom, eight of the nation’s top AIDS researchers gathered at George Washington University for a special meeting. But they weren’t there to discuss their latest findings, or to devise new strategies for fighting the deadly disease, or even to enjoy the Washington spring. Instead, says Berke

Written byMarcia Barinaga
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

BERKELEY, CALIF.—On a Saturday early in April, as Washington’s famous cherry trees began to blossom, eight of the nation’s top AIDS researchers gathered at George Washington University for a special meeting. But they weren’t there to discuss their latest findings, or to devise new strategies for fighting the deadly disease, or even to enjoy the Washington spring. Instead, says Berkeley molecular biologist Harry Rubin, one of the participants, “the forum was called to lynch Peter Duesberg.”

That description may be a bit too strong, a bit too bitter. But then, feelings run deep when it comes to Peter Duesberg. As anyone who reads Science or Spin or most newspapers knows by now, the Berkeley biologist has had the temerity not just to challenge the current dogma of AIDS—that the disease is caused by the human immunodeficiency virus—but to do it in a flamboyant and highly public fashion. Duesberg’s stance, argue ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA